Noninvasix Medical Devices
Galveston, US · 7 known investors
Find your way into Noninvasix Medical Devices
Sign up to see every warm intro you have to Noninvasix Medical Devices
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Noninvasix Medical Devices team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Noninvasix develops a patented optoacoustic platform that non-invasively and continuously measures central venous oxygen saturation to help ICU clinicians diagnose and monitor tissue hypoxia in sepsis and septic shock patients in real time. The technology is aimed at critical care settings, with planned applications in fetal monitoring, neonatal care, traumatic brain injury, and blood loss.
Founders & leadership


Investors · 7
How we know: Green Park & Golf Ventures's portfolio page · tmc.edu · Not right? Tell us
How we know: Health Wildcatters's portfolio page · Not right? Tell us
How we know: TMC Venture Fund's portfolio page · funding news · press coverage · Not right? Tell us
How we know: tmc.edu · Not right? Tell us
Also in the syndicate · 1
Funding
SEC filings, press & company announcements$4M disclosed across 1 of 2 rounds · 2020–2021
- Undisclosed amountSeries Seed Funding RoundFeb 2021
Texas Medical Center Venture Fund (lead), GPG Ventures, Philips
Source ↗
▶$4MraisedJun 2020 · 18 investors · Other Health CareRule 506(b)
- Thomas LubyDirector
- Graham L. RandallExecutive Officer, Director
- Donald S. ProughExecutive Officer, Director
- Michael LoweDirector
- Offering amount
- $4M
- Amount sold
- $4M
- First sale
- Mar 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Noninvasix Medical Devices do?
- Noninvasix develops a patented optoacoustic platform that non-invasively and continuously measures central venous oxygen saturation to help ICU clinicians diagnose and monitor tissue hypoxia in sepsis and septic shock patients in real time. The technology is aimed at critical care settings, with planned applications in fetal monitoring, neonatal care, traumatic brain injury, and blood loss.
- Who founded Noninvasix Medical Devices?
- Noninvasix Medical Devices was founded by Donald Prough.
- Who are Noninvasix Medical Devices's investors?
- Noninvasix Medical Devices's investors include Green Park & Golf Ventures, Health Wildcatters, Rockies Venture Club, Texas Ventures, TMC Venture Fund, Philips Ventures.
- How much funding has Noninvasix Medical Devices raised?
- Noninvasix Medical Devices has disclosed $4M raised across 1 of its 2 known rounds.
- Where is Noninvasix Medical Devices headquartered?
- Noninvasix Medical Devices is headquartered in Galveston, US.


